Meyer DK and Reboli AC (2005) Rhodococcus equi. In Principles and Practice of Infectious Diseases, 2472-2478 (Eds Mandell GL et al.) Philadelphia: Elsevier
Pulmonary infection from Rhodococcus equi after renal transplantation: Review of the literature [French]
Gallen F et al. (1999) Pulmonary infection from Rhodococcus equi after renal transplantation: review of the literature [French]. Nephrologie 20: 383-386
Isolation of rare opportunistic pathogens in Hungary: Case report and short review of the literature. Rhodococcus equi
Szabó B et al. (2000) Isolation of rare opportunistic pathogens in Hungary: case report and short review of the literature. Rhodococcus equi. Acta Microbiol Immunol Hung 47: 9-14
Pulmonary infection caused by Rhodococcus equi in a kidney and pancreas transplant recipient: A case report
La Rocca E et al. (1998) Pulmonary infection caused by Rhodococcus equi in a kidney and pancreas transplant recipient: a case report. Transplantation 65: 1524-1525
Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: Diagnosis by fine-needle aspiration biopsy
Simsir A et al. (2001) Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy. Diagn Cytopathol 24: 129-131
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
Kasiske B et al. (2004) Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 4 (Suppl 7): S13-S53
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial
Holdaas H et al. (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361: 2024-2031
Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: An update focused on clarithromycin, azithromycin and dirithromycin
Westphal JF (2000) Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. J Clin Pharmacol 50: 285-295